Malaria vaccine: the latest news from RTS,S/AS01E vaccine (Q45883531)

17 December 2017

title

Malaria vaccine: the latest news from RTS,S/AS01E vaccine (English)

1 reference

17 December 2017

0 references

1 reference

Gloria Gonzalez-Aseguinolaza

series ordinal

1

1 reference

17 December 2017

publication date

1 March 2009

1 reference

17 December 2017

Expert Review of Vaccines

published in

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

285-288

1 reference

17 December 2017

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Rationale for development of a synthetic vaccine against plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

CD4+ cytolytic T cell clone confers protection against murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.3.285

21 January 2018

Identifiers

DOI

10.1586/14760584.8.3.285

1 reference

17 December 2017

1 reference

17 December 2017